PTC Therapeutics Stock Forecast

Stock Price Forecast

The 16 analysts that cover PTC Therapeutics stock have a consensus rating of "Buy" and an average price target of $80.94, which forecasts a 22.40% increase in the stock price over the next year. The lowest target is $50 and the highest is $119.

Price Target: $80.94 (+22.40%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$50	$80.94	$80	$119
Change	-24.39%	+22.40%	+20.97%	+79.95%

* Price targets were last updated on Feb 23, 2026.

Analyst Ratings

The average analyst rating for PTC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	4	4	4	4	4
Buy	6	7	6	7	7	7
Hold	3	4	5	5	5	4
Sell	0	0	0	0	0	0
Strong Sell	2	2	2	2	1	1
Total	15	17	17	18	17	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $90 → $92	Buy	Maintains	$90 → $92	+39.12%	Feb 23, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $93 → $86	Buy	Maintains	$93 → $86	+30.05%	Feb 20, 2026
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $87 → $82	Hold	Maintains	$87 → $82	+24.00%	Feb 20, 2026
Tazeen Ahmad B of A Securities	B of A Securities	Strong Buy Maintains $97 → $93	Strong Buy	Maintains	$97 → $93	+40.63%	Feb 20, 2026
Eliana Merle Barclays	Barclays	Hold → Buy Upgrades $68 → $119	Hold → Buy	Upgrades	$68 → $119	+79.95%	Jan 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.03B

from 1.73B

-40.72%

from 1.73B

Revenue Next Year

1.22B

from 1.03B

19.30%

from 1.03B

EPS This Year

-0.65

from 7.78

EPS Next Year

1.40

from -0.65

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	538.59M	698.80M	937.82M	806.78M	1.73B	1.03B	1.22B
Revenue Growth	41.45%	29.75%	34.20%	-13.97%	114.51%	-40.72%	19.30%
EPS	-7.43	-7.79	-8.37	-4.73	7.78	-0.65	1.40
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	47.11
No. Analysts	-	-	-	-	-	17	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.5B	2.0B
Avg	1.0B	1.2B
Low	695.1M	770.1M

Revenue Growth

Revenue Growth	2026	2027
High	-14.4%	97.2%
Avg	-40.7%	19.3%
Low	-59.8%	-24.9%

EPS Forecast

EPS	2026	2027
High	2.97	8.62
Avg	-0.65	1.40
Low	-2.90	-4.69

EPS Growth

EPS Growth	2026	2027
High	-61.8%	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.